Here's Why Labcorp (LH) is a Strong Momentum Stock

Company Overview - Labcorp Holdings, Inc. is a leading healthcare diagnostics company providing comprehensive clinical laboratory services and end-to-end drug development support [12] - The company acquired Covance in 2015, enhancing its capabilities in drug development services for the pharmaceutical and biotechnology industries [12] Investment Analysis - Labcorp has a Zacks Rank of 3 (Hold) and a VGM Score of B, indicating a moderate investment potential [13] - The Momentum Style Score for Labcorp is B, with shares increasing by 9.9% over the past four weeks [13] - For fiscal 2025, eight analysts have revised their earnings estimates upwards in the last 60 days, with the Zacks Consensus Estimate increasing by $0.04 to $16.05 per share [13] - Labcorp has an average earnings surprise of 2.3%, suggesting a positive trend in earnings performance [13] Investment Recommendation - With a solid Zacks Rank and top-tier Momentum and VGM Style Scores, Labcorp is recommended for investors' consideration [14]